Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Tendinopathy Market is Growing at a 0.6% CAGR Driven By the Potential Pipeline Drugs During the Study Period [2018-2030], States DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

28 Jul, 2021, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

The Tendinopathy market is expected to boom with the launch of the potential Tendinopathy pipeline drugs such as Micronized DHACM and Amniotic Fluid Tissue in the forecasted period (2021-2030).

LAS VEGAS, July 28, 2021 /PRNewswire/ -- DelveInsight's "Tendinopathy Market" report provides a thorough comprehension of the Tendinopathy historical and forecasted epidemiology and the Tendinopathy market trends in the 7MM [the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom) and Japan]. The Tendinopathy market report also proffers an analysis of the current Tendinopathy treatment algorithm/practice, market drivers, market barriers, and unmet medical needs. 

 Some of the necessary takeaways from the Tendinopathy Market Research Report 

  • Several key pharmaceutical companies like MiMedx Group, R3 Stem Cell, Novartis Pharmaceuticals, University of Wisconsin-Madison, General Electric, Ipsen, Orthocell Limited, and others are developing novel products to improve the Tendinopathy treatment outlook. 
  • Tendinopathy Market growth will expand due to the factors such as the rising incidence, research and development, preclinical models, and the approval of pipeline drugs in the forecasted period. Nevertheless, the growth of the Tendinopathy Market will impede because of delayed diagnosis, misdiagnosis, and the limitations associated with the current treatment. 
  • The current market depends on therapeutic agents or those who fail to respond to these drugs and go for surgery. However, by looking at the pipeline, it has been found that many allografts, regenerative medicine treatments with amniotic fluid, and cell therapy are under development for Tendinopathy. Moreover, if they get approved in the coming years, they will capture all the market of NSAIDs, opioids, and other therapies that are providing symptomatic management. 

For further information on Market Impact by Therapies, visit: Tendinopathy Drugs Market Analysis 

Tendinopathy is a failed healing response of the tendon, with the haphazard proliferation of tenocytes, intracellular abnormalities in tenocytes, disruption of collagen fibers, and a subsequent increase in the noncollagenous matrix.

DelveInsight estimates that the total Tendinopathy incident cases were found to be 29,282,773 cases in the 7MM in 2020. Among these countries, the United States patients account for the highest number of Tendinopathy cases. 

The Tendinopathy Market Analysis Report provides historical as well as forecasted epidemiological analysis segmented into: 

  • Total Tendinopathy Incident Cases 
  • Gender-specific Incident Cases of Tendinopathy 
  • Type-specific Incident Cases of Tendinopathy 
  • Region-specific Incident Cases of Tendinopathy 

Get a complete epidemiological segmentation breakdown @ Tendinopathy Epidemiological Analysis 

Tendinopathy Treatment Market 

The traditional Tendinopathy treatment modalities aimed at controlling inflammation, such as corticosteroid injections and nonsteroidal anti-inflammatory medications (NSAIDs), may not be the most effective options. Platelet-Rich Plasma (PRP) is another technique that has been widely used in orthopedic surgery and sports medicine to treat tendon injuries.

The current Tendinopathy treatment regimen for the management includes rest, ice, and over-the-counter (OTC) pain relievers. Certain medications, including over-the-counter non-steroidal anti-inflammatory medications, such as ibuprofen and naproxen, are recommended for managing the condition. 

Out of the current treatment market, most of the Tendinopathy market size was generated by Surgery + NSAIDs, which is around USD 6,252 million in the 7MM in 2020. However, with the expected approval of the emergence of emerging products, the market size of Surgery + NSAIDs is expected to decrease in 2030. 

The Tendinopathy pipeline possesses potential drugs as monotherapies as well as combination therapies. The current market of Tendinopathy anticipates the emergence of emerging products, namely Micronized DHACM and Amniotic Fluid Tissue. Most of the drugs are approved for tendonitis; hence, there is a need to approve more tendinopathy-specific drugs, and robust pipeline candidates are expected to intensify future competition.

Final comments on the Tendinopathy Market growth 

The growth of the Tendinopathy Market will increase owing to the Tendinopathy incidence in recent years and the overall rise in extreme and overuse sports. Significant advancements in the field of Tendinopathy therapeutics are observed. In addition, various organizations and research institutes are undertaking research activities to discover successful Tendinopathy treatments, and a large number of clinical trials are recruiting Tendinopathy patient volunteers. Moreover, gene therapy becomes a promising method for facilitating the trafficking of growth factors to the injured site, potentially allowing sustained temporal delivery. Novel mini-invasive procedures that target underlying pathology, such as abnormal neoinnervation, are being developed and are initially promising.

Nevertheless, the lack of understanding of the disease pathophysiology and clinical relevance may represent a missed opportunity to make the correct diagnosis, potentially leading to a delayed diagnosis and misdiagnosis. Despite many clinical advances in treating Tendinopathies, there remains an unmet need for effective therapeutic strategies to augment the intrinsic and surgical repair. Already available off-labeled drugs might offer tough competition to emerging ones. Also, the communication gap among doctors and patients is one of the primary reasons for unsatisfactory patient care currently and might hinder the growth of the Tendinopathy market and access to medications.

Scope of the Tendinopathy Market Insight Report 

  • Geography Covered: The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. 
  • Study Period: 3-year historical and 10-year forecasted analysis (2018-2030).
  • Tendinopathy Markets Segmentation: By Geographies and By Tendinopathy Therapies (Historical and Forecasted, Current and Upcoming) 
  • Dominant Market Companies investigating its candidates for Tendinopathy: MiMedx Group, R3 Stem Cell, Novartis Pharmaceuticals, University of Wisconsin-Madison, General Electric, Ipsen, Orthocell Limited, and several others. 
  • Analysis: Comparative and conjoint analysis of emerging therapies. 
  • Case Studies
  • KOL's Views
  • Analyst's View

Request for a Webex demo of the report @ Tendinopathy Therapeutics Market

Table of Contents 

1

Tendinopathy Key Insights

2

Tendinopathy Report Introduction 

3

Tendinopathy Market Overview at a Glance       

4

Executive Summary of Tendinopathy

5

Tendinopathy Disease Background and Overview 

6

Tendinopathy Epidemiology and Patient Population 

7

Country Wise-Epidemiology of Tendinopathy 

7.1

The United States

7.2

EU5 Countries

7.2.1

Germany

7.2.2

France

7.2.3

Italy

7.2.4

Spain

7.2.5

The United Kingdom

7.3

Japan

8

Organizations contributing towards Tendinopathy

9

Tendinopathy  Patient Journey 

10

Tendinopathy Case Reports

11

Tendinopathy Emerging Therapies

11.1

Micronized DHACM (AmnioFix): MiMedx Group

11.2

 Amniotic Fluid Tissue: R3 Stem Cell

11.3

 Secukinumab (AIN457): Novartis Pharmaceuticals

11.4

 Platelet-rich Plasma: University of Wisconsin-Madison/General Electric

11.5

Botulinum toxin A (Dysport 500 Unit Powder): Ipsen

11.6

Ortho-ATI: Orthocell Limited

12

Tendinopathy 7MM Market Analysis

12.1

The United States Tendinopathy Market Size

12.2

EU-5 Tendinopathy Market Size

12.2.1

Germany Market Size

12.2.2

France Market Size

12.2.3

Italy Market Size

12.2.4

Spain Market Size

12.2.5

The United Kingdom Market Size

12.2.3

Japan Tendinopathy Market Size

13

KOL Views

14

Tendinopathy Market Drivers

15

Tendinopathy Market Barriers

16

Tendinopathy SWOT Analysis

17

Tendinopathy Unmet Needs

18

Appendix

19

DelveInsight Capabilities

20

Disclaimer

21

About DelveInsight

Browse full report with detailed TOC with charts, figures, tables @ Tendinopathy Diagnostics Market Report

View Other Reports

  • Tendinopathy Epidemiology Forecast

DelveInsight's Tendinopathy - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Tendinopathy.

  • Pachyonychia Congenita Market 

Pachyonychia Congenita Market Research Report delivers an in-depth understanding of the Pachyonychia Congenita Market Trends, Pipeline Therapies, Companies, and Epidemiology Forecast in 7MM. 

  • Anemia in CKD patients Market

DelveInsight's Anemia in CKD patients - Market Insights, Epidemiology, and Market Forecast - 2030 report provides a detailed overview of the disease and in-depth understanding of historical and Epidemiology Forecast in 7MM. 

  • Atherosclerotic Cardiovascular Disease Market

DelveInsight's Atherosclerotic Cardiovascular Disease Market Report 2030 delivers an in-depth understanding of the disease, historical, forecasted epidemiology, and market trends in the 7MM.

  • Balloon Catheters Market

DelveInsight's 'Balloon Catheters Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Balloon Catheters, historical, forecasted epidemiology, and market trends in the 7MM. Key Players such as Cardionovum GmbH, Boston Scientific Corporation, Biotronik,  Abbott,  Terumo Medical Corporation,  Medtronic, and others are developing devices. 

Browse Blog Posts

  • Explore Cost-effectiveness, Advanced Technology, Rising Demand that Pushes the Insulin Delivery Devices Market
  • Read FemTech Market: With 100+ Startups in the domain, Women Healthcare is Witnessing a Huge Upliftment

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach. 

Contact Us:

Shruti Thakur
info@delveinsight.com   
+1(919)321-6187
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg  

Modal title

Also from this source

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

MCR Therapies Market Set to Grow Rapidly Across the 7MM During the Forecast Period (2020-2034) with New Indications and Pipeline Advancements | DelveInsight

DelveInsight's MCR Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive understanding of ...

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Lewy body dementia (LBD) is a progressive neurological condition characterized by the accumulation of abnormal alpha-synuclein protein in the brain....

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.